The DOI matches its Crossref record; 722 of the 722 references it cites were found in a registry or an index.
Current and Potential Drugs for Treatment of Obesity
Abstract
I. Introduction II. Criteria for Evaluating the Efficacy of Antiobesity Treatment III. Physiological and Pharmacological Mechanisms to Reduce Food Intake A. Peripherally acting agents B. Centrally acting agents IV. Drugs That Alter Metabolism A. Preabsorptive agents B. Postabsorptive modifiers of nutrient metabolism V. Drugs That Increase Energy Expenditure A. Thyroid hormone B. Adrenergic thermogenic drugs VI. Conclusion
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–600 of 722
Pharmacology of eating disorders: Theoretical and clinical developments
Winn, P. (1987) · Appetite · doi:10.1016/0195-6663(87)90058-4 · Cited by 66
Acheson, K. J., Ravussin, É., Schoeller, D. A., Christin, L., Bourquin, L. D., Baertschi, P., Danforth, E., & Jéquier, E. (1988) · Metabolism · doi:10.1016/0026-0495(88)90035-2 · Cited by 65
Efficacy and Safety of Long‐Term Fluoxetine Treatment of Obesity ‐ Maximizing Success
GOLDSTEIN, D. J., Rampey, A. H., Roback, P., Wilson, M. G., Hamilton, S. H., Sayler, M. E., & Tollefson, G. D. (1995) · Obesity Research · doi:10.1002/j.1550-8528.1995.tb00216.x · Cited by 65
Wadden, T. A., Bartlett, S. J., Foster, G. D., Greenstein, R. A., Wingate, B. J., Stunkard, A. J., & Letizia, K. A. (1995) · Obesity Research · doi:10.1002/j.1550-8528.1995.tb00189.x · Cited by 65
Li, B.-H., Spector, A. C., & Rowland, N. E. (1994) · Brain Research · doi:10.1016/0006-8993(94)91881-3 · Cited by 64
Smith, B. K., York, D. A., & Bray, G. A. (1999) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1999.277.3.r802 · Cited by 64
Self-citationIntravenous infusion of bombesin reduces food intake in humans
Muurahainen, N., Kissileff, H. R., & Pi‐Sunyer, F. X. (1993) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1993.264.2.r350 · Cited by 64
Neural control of brown adipose tissue thermogenesis, hypertrophy, and atrophy
Himms‐Hagen, J. (1991) · Frontiers in Neuroendocrinology · Cited by 64
Pharmacology of thermogenic drugs
Astrup, A. V., Toubro, S., Christensen, N., & QUAADE, F. (1992) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/55.1.246s · Cited by 63
Reitsma, J. B., Cabezas, M. C., de Bruin, T. W., & Erkelens, D. W. (1994) · Metabolism · doi:10.1016/0026-0495(94)90095-7 · Cited by 63
Heal, D. J., Frankland, A. T. J., Gosden, J., Hutchins, L. J., Prow, M. R., Luscombe, G. P., & Buckett, W. R. (1992) · Psychopharmacology · doi:10.1007/bf02245152 · Cited by 63
β-Casomorphins Stimulate and Enterostatin Inhibits the Intake of Dietary Fat in Rats
Lin, L., Umahara, M., York, D. A., & Bray, G. A. (1998) · Peptides · doi:10.1016/s0196-9781(97)00307-0 · Cited by 63
Self-citationProposed Standards for Judging the Success of the Treatment of Obesity
Atkinson, R. L. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-7_part_2-199310011-00010 · Cited by 63
Dryden, S., Wang, Q., Frankish, H. M., & Williams, G. (1996) · Peptides · doi:10.1016/0196-9781(96)00142-8 · Cited by 63
Fenfluramine in Prader-Willi syndrome: a double blind, placebo controlled trial.
Selikowitz, M., Sunman, J., Pendergast, A., & Wright, S. (1990) · Archives of Disease in Childhood · doi:10.1136/adc.65.1.112 · Cited by 63
2,5-anhydro-D-mannitol acts in liver to initiate feeding
Tordoff, M. G., Rawson, N. E., & Friedman, M. I. (1991) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1991.261.2.r283 · Cited by 63
Obesity: Pathophysiology, Psychology, and Treatment
Dietz, W. H. (1995) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/62.1.158-b · Cited by 63
Phenylpropanolamine : risks, benefits, and controversies
Morgan, J. P., Kagan, D. V., & Brody, J. S. (1985) · Praeger eBooks · Cited by 62
Obesity: Pathophysiology Psychology and Treatment
Blackburn, G. L., & Kanders, B. S. (1995) · Medical Entomology and Zoology · Cited by 61
Ergosteroids II: Biologically Active Metabolites and Synthetic Derivatives of Dehydroepiandrosterone
Lardy, H. A., Kneer, N. M., Wei, Y., Partridge, B., & Marwah, P. (1998) · Steroids · doi:10.1016/s0039-128x(97)00159-1 · Cited by 61
Goodall, E., Oxtoby, C., Richards, R. P., Watkinson, G., Brown, D., & Silversonte, T. (1988) · The British Journal of Psychiatry · doi:10.1192/bjp.153.2.208 · Cited by 61
Stanko, R. T., Tietze, D., & Arch, J. (1992) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/55.4.771 · Cited by 60
Smith, B. K., York, D. A., & Bray, G. A. (1996) · Brain Research Bulletin · doi:10.1016/0361-9230(95)02086-1 · Cited by 60
Self-citationGalanin in the hypothalamus of fed and fasted lean and obese Zucker rats
Beck, B., Burlet, A. J., Nicolas, J., & Burlet, C. R. (1993) · Brain Research · doi:10.1016/0006-8993(93)90019-j · Cited by 60
Differential effects of enterostatin, galanin and opioids on high-fat diet consumption
Barton, C., Lin, L., York, D. A., & Bray, G. A. (1995) · Brain Research · doi:10.1016/0006-8993(95)00966-8 · Cited by 60
Self-citationLong-term weight control study III (weeks 104 to 156)
WEINTRAUB, M. I., Sundaresan, P. R., Schuster, B., Moscucci, M. M., & Stein, E. (1992) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1992.71 · Cited by 60
Structure-activity study of .beta.-adrenergic agents using the SIMCA method of pattern recognition
Dunn, W. J., Wold, S., & Martin, Y. C. (1978) · Journal of Medicinal Chemistry · doi:10.1021/jm00207a015 · Cited by 59
Davis, H. R., Mullins, D. E., Pines, J. M., Hoos, L. M., France, C. F., Compton, D. S., Graziano, M. P., Sybertz, E. J., Strader, C. D., & van Heek, M. (1998) · Obesity Research · doi:10.1002/j.1550-8528.1998.tb00329.x · Cited by 59
Effect of triiodothyronine on some metabolic responses of obese patients
Bray, G. A., Melvin, K. E. W., & CHOPRA, I. J. (1973) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/26.6.715 · Cited by 59
Self-citationEffects of Chronic Beta Receptor Stimulation on Glucose Metabolism
SCHEIDEGGER, K., Robbins, D. C., & Danforth, E. (1984) · Diabetes · doi:10.2337/diab.33.12.1144 · Cited by 59
Hindbrain GRP receptor blockade antagonizes feeding suppression by peripherally administered GRP
Ladenheim, E. E., Taylor, J. E., Coy, D. H., Moore, K. A., & Moran, T. H. (1996) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1996.271.1.r180 · Cited by 59
Efficacies of dexfenfluramine and fluoxetine in preventing weight gain after smoking cessation
Spring, B. J., Wurtman, J. J., Wurtman, R. J., El-Khoury, A. E., Goldberg, H., Mcdermott, J., & Pingitore, R. (1995) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/62.6.1181 · Cited by 58
Hillebrand, I., Boehme, K., Frank, G., Fink, H., & Berchtold, P. (1979) · Research in Experimental Medicine · doi:10.1007/bf01851237 · Cited by 58
A Study of Fluoxetine in Obese Elderly Patients with Type 2 Diabetes
Connolly, V., Gallagher, A., & Kesson, C. M. (1995) · Diabetic Medicine · doi:10.1111/j.1464-5491.1995.tb00505.x · Cited by 58
Usefulness of Fluoxetine in Obese Non‐Insulin‐Dependent Diabetics: A Multicenter Study
Daubresse, J., Kolanowski, J., Krzentowski, G., Kutnowski, M., Scheen, A. J., & Gaal, L. V. (1996) · Obesity Research · doi:10.1002/j.1550-8528.1996.tb00247.x · Cited by 58
Etc, G. (1991) · Cited by 58
Hill, A. J., & Blundell, J. E. (1990) · PubMed · Cited by 57
GABA-related feeding control in genetically obese rats
Tsujii, S., & Bray, G. A. (1991) · Brain Research · doi:10.1016/0006-8993(91)90491-d · Cited by 57
Self-citationBouillaud, F., Raimbault, S., & Ricquier, D. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)80318-8 · Cited by 57
Bray, G. A. (1996) · The Lancet · doi:10.1016/s0140-6736(05)66103-x · Cited by 56
Self-citationCalorigenic Effect of Human Growth Hormone in Obesity1
Bray, G. A. (1969) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-29-1-119 · Cited by 56
Self-citationStanko, R. T., Tietze, D., & Arch, J. (1992) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/56.4.630 · Cited by 56
Breum, L., Pedersen, J. K., Ahlstrøm, F., & Frimodt-Møller, J. (1994) · PubMed · Cited by 55
Obesity: Its Pathogenesis And Management
Silverstone, T. (1975) · Springer eBooks · doi:10.1007/978-94-011-7155-7 · Cited by 55
SCHEIDEGGER, K., O’Connell, M., Robbins, D. C., & Danforth, E. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-58-5-895 · Cited by 55
Hormone responses to fenfluramine and placebo challenge in endogenous depression
Lichtenberg, P., Shapira, B., Gillon, D., Kindler, S., Cooper, T. B., Newman, M. E., & Lerer, B. (1992) · Psychiatry Research · doi:10.1016/0165-1781(92)90128-p · Cited by 54
The effects of the TRH metabolite cyclo(His-Pro) and its analogs on feeding
Kow, L., & Pfaff, D. W. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90291-9 · Cited by 54
Wurtman, J. J. (1990) · Drugs · doi:10.2165/00003495-199000393-00006 · Cited by 54
Long-term weight control study IV (weeks 156 to 190)
WEINTRAUB, M. I., Sundaresan, P. R., Schuster, B., Averbuch, M., Stein, E., Cox, C., & Byrne, L. (1992) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1992.72 · Cited by 54
D-fenfluramine-induced prolactin and cortisol release in major depression: Response to treatment
O’Keane, V., McLoughlin, D. M., & Dinan, T. G. (1992) · Journal of Affective Disorders · doi:10.1016/0165-0327(92)90009-u · Cited by 54
Fluoxetine treatment of the obese diabetic.
Gray, D. S., Fujioka, K., Devine, W., & Bray, G. A. (1992) · PubMed · Cited by 54
Self-citationDexfenfluramine treatment of obesity: a double blind trial with post trial follow up.
O'Connor, H. T., Richman, R. M., Steinbeck, K. S., & Caterson, I. D. (1995) · PubMed · Cited by 54
Lovejoy, J. C., Smith, S. R., Bray, G. A., DeLany, J. P., Rood, J. C., Gouvier, D., WINDHAUSER, M. M., Ryan, D. H., Macchiavelli, R., & Tulley, R. T. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.3.3827 · Cited by 53
Self-citationOverweight and Weight Management: The Health Professional's Guide to Understanding and Practice
Clark, N. G. (1998) · Europe PMC (PubMed Central) · Cited by 53
Thompson, J. L. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.5.1477 · Cited by 53
Food intake of lean and obese Zucker rats following ventricular infusions of adrenergic agonists
Tsujii, S., & Bray, G. A. (1992) · Brain Research · doi:10.1016/0006-8993(92)91001-u · Cited by 52
Self-citationWeizman, A., Mark, M., Gil‐Ad, I., Tyano, S., & Laron, Z. (1988) · Clinical Neuropharmacology · doi:10.1097/00002826-198806000-00007 · Cited by 52
BEHAVIORAL THERAPY FOR OBESITY
Williamson, D. A., & Perrin, L. A. (1996) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70363-7 · Cited by 52
Obesity--the inevitable penalty of civilisation?
Prentice, A. M. (1997) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a011610 · Cited by 52
Long-term weight control study V (weeks 190 to 210)
WEINTRAUB, M. I., Sundaresan, P. R., Schuster, B., Averbuch, M., Stein, E., & Byrne, L. (1992) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1992.73 · Cited by 52
The pharmacokinetics of dexfenfluramine in obese and non-obese subjects.
CHEYMOL, G., WEISSENBURGER, J., Poirier, J., & Gellee, C. (1995) · PubMed · Cited by 52
Physiological Regulation of Body Weight and the Issue of Obesity
Keesey, R. E. (1989) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30689-7 · Cited by 51
d-Amphetamine: effects on memory in a depressed population.
Reus, V. I., Silberman, E. K., Post, R. M., & Weingartner, H. (1979) · PubMed · Cited by 51
Balcioglu, A., & Wurtman, R. J. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800589 · Cited by 50
Reduced norepinephrine turnover in mice with monosodium glutamate-induced obesity
Yoshida, T., Nishioka, H., Nakamura, Y., & Kondo, M. (1984) · Metabolism · doi:10.1016/0026-0495(84)90238-5 · Cited by 50
Aminorex, Dexfenfluramine, and Primary Pulmonary Hypertension
Kramer, M. S., & Lane, D. A. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(97)00289-8 · Cited by 50
Bipiperidyl Mustard, A New Obesifying Agent in the Mouse
Rutman, R. J., Lewis, F. S., & Bloomer, W. D. (1966) · Science · doi:10.1126/science.153.3739.1000 · Cited by 49
Sumatriptan decreases food intake and increases plasma growth hormone in healthy women
Boeles, S., Williams, C., Campling, G. M., Goodall, E. M., & Cowen, P. J. (1997) · Psychopharmacology · doi:10.1007/s002130050178 · Cited by 49
Nielsen, J. A., Chapin, D., Johnson, J., & Torgersen, L. K. (1992) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/55.1.185s · Cited by 49
Mathus-Vliegen, E. M. H., Van, D. V. K., KOK, A. M. E., & A., A. M. (1992) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1992.tb00560.x · Cited by 48
The Long‐Term Management of Obesity in General Practice
Silverstone, J. T., & Solomon, T. (1965) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.1965.tb03144.x · Cited by 48
Obesity treatment : establishing goals, improving outcomes, and reviewing the research agenda
Allison, D. B., & Pi-Sunyer, X. (1995) · Cited by 47
Panksepp, J., & Meeker, R. B. (1976) · Physiology & Behavior · doi:10.1016/0031-9384(76)90248-1 · Cited by 47
The Fen‐Phen Finale: A Study of Weight Loss and Valvular Heart Disease
Wadden, T. A., Berkowitz, R. I., Silvestry, F. E., Vogt, R. A., Sutton, M. G. S. J., Stunkard, A. J., Foster, G. D., & Aber, J. L. (1998) · Obesity Research · doi:10.1002/j.1550-8528.1998.tb00350.x · Cited by 47
Williamson, D. F. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1996.tb03904.x · Cited by 47
Effects of cholecystokinin on sympathetic activity to interscapular brown adipose tissue
Yoshimatsu, H., Egawa, M., & Bray, G. A. (1992) · Brain Research · doi:10.1016/0006-8993(92)91486-x · Cited by 47
Self-citationKj, L., Forbes, J. A., Gw, B., & Gf, G. (1974) · PubMed · Cited by 46
Bray, G. A., Raben, M. S., Londono, J. H., & Gallagher, T. F. (1971) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-33-2-293 · Cited by 46
Self-citationEvaluation of Drugs for Treating Obesity
Bray, G. A. (1995) · Obesity Research · doi:10.1002/j.1550-8528.1995.tb00209.x · Cited by 46
Self-citationLong-term use of diethylpropion in obesity
McKay, R. H. G. (1973) · Current Medical Research and Opinion · doi:10.1185/03007997309111712 · Cited by 46
Diethylpropion in the Treatment of "Refractory" Obesity
Seaton, D., Duncan, L. J. P., Rose, K., & Scott, A. M. (1961) · BMJ · doi:10.1136/bmj.1.5231.1009 · Cited by 46
LESSONS FROM ANIMAL MODELS OF OBESITY
York, D. A. (1996) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70354-6 · Cited by 46
Effect of Thyroid Hormone on Body Composition in Myxedema and Obesity
Kyle, L. H., Ball, M. F., & Doolan, P. D. (1966) · New England Journal of Medicine · doi:10.1056/nejm196607072750103 · Cited by 46
Tsujii, S., & Bray, G. A. (1998) · Physiology & Behavior · doi:10.1016/s0031-9384(97)00518-0 · Cited by 45
Self-citationRegulation of Body Weight. Biological and Behavioral Mechanisms.
Bouchard, C., & Bray, G. A. (1996) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 45
Self-citationThe Effects of Dexfenfluramine on Blood Glucose Control in Patients with Type 2 Diabetes
Willey, K. A., Molyneaux, L. M., Overland, J., & Yue, D. K. (1992) · Diabetic Medicine · doi:10.1111/j.1464-5491.1992.tb01793.x · Cited by 45
Obesity: new directions in assessment and management
(1996) · Choice Reviews Online · doi:10.5860/choice.33-3951 · Cited by 44
Lasagna, L. C. (1988) · Cited by 44
Persistent lipolytic effect of exogenous growth hormone during caloric restriction
Snyder, D. K., Underwood, L. E., & Clemmons, D. R. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80396-9 · Cited by 44
Combined Drug Treatment of Obesity
Atkinson, R. L., Blank, R. C., Loper, J. F., Schumacher, D., & Lutes, R. A. (1995) · Obesity Research · doi:10.1002/j.1550-8528.1995.tb00218.x · Cited by 44
Clinical studies with phenylpropanolamine: a metaanalysis
Greenway, F. (1992) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/55.1.203s · Cited by 44
Self-citationHorton, T. J., & Geissler, C. A. (1996) · PubMed · Cited by 43
Determinants of the Pressor Effect of Phenylpropanolamine in Healthy Subjects
Blackburn, G. L. (1989) · JAMA · doi:10.1001/jama.1989.03420220081031 · Cited by 43
Lijesen, G., Theeuwen, I. M., Assendelft, W. J., & van der Wal, G. (1995) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1995.tb05779.x · Cited by 43
Chronic intrahypothalamic insulin infusion in the rat: Behavioral specificity
McGowan, M. K., Andrews, K. M., Fenner, D., & Grossman, S. P. (1993) · Physiology & Behavior · doi:10.1016/0031-9384(93)90320-f · Cited by 43
Clinical Studies with Mazindol
Inoue, S. (1995) · Obesity Research · doi:10.1002/j.1550-8528.1995.tb00226.x · Cited by 43
A comparative trial of different regimens of fenfluramine and phentermine in obesity.
Jm, S., Jf, M., & Duncan, L. J. P. (1973) · PubMed · Cited by 43
Lafrenière, F., Lambert, J., Rasio, E., & Serri, O. (1993) · PubMed · Cited by 43
Maes, M. H. J., D'Hondt, P., Suy, E., Minner, B., Vandervorst, C., & Raus, J. (1991) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(91)90007-n · Cited by 42
Foltin, R. W., & Fischman, M. W. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01758.x · Cited by 42
Enzi, G., Baritussio, A., Marchiori, E., & Crepaldi, G. (1976) · Journal of International Medical Research · doi:10.1177/030006057600400504 · Cited by 42
Lovejoy, J. C. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.3.765 · Cited by 41
Lateral hypothalamic lesions and activity of the sympathetic nervous system
Arase, K., Sakaguchi, T., & Bray, G. A. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90421-8 · Cited by 41
Self-citationThe anorectic and hypotensive effect of fenfluramine in obesity.
Hudson, K. D. (1977) · PubMed · Cited by 41
Mitchell, T. H., Ellis, R. D. M., Smith, S. A., Robb, G., & Cawthorne, M. A. (1989) · PubMed · Cited by 41
Plasma phentermine levels, weight loss and side-effects.
Douglas, A., Douglas, J., Ce, R., & Jf, M. (1983) · PubMed · Cited by 40
Ondansetron, a 5-HT3 receptor antagonist, partially attenuates the effects of amphetamine
Silverstone, P. H., Oldman, D., Johnson, B., & Cowen, P. J. (1992) · International Clinical Psychopharmacology · doi:10.1097/00004850-199200710-00005 · Cited by 40
AVRITH, D. B., & Mogenson, G. J. (1978) · Brain Research · doi:10.1016/0006-8993(78)91131-9 · Cited by 40
Long-term weight control study VII (weeks 0 to 210)
WEINTRAUB, M. I., Sundaresan, P. R., & Schuster, B. (1992) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1992.75 · Cited by 40
Obesity and diabetes and the beta-3 adrenergic receptor
Danforth, E., & Himms‐Hagen, J. (1997) · European Journal of Endocrinology · doi:10.1530/eje.0.1360362 · Cited by 40
Vagal‐Central Nervous System Interactions Modulate the Feeding Response to Peripheral Enterostatin
Tian, Q., Nagase, H., York, D. A., & Bray, G. A. (1994) · Obesity Research · doi:10.1002/j.1550-8528.1994.tb00101.x · Cited by 40
Self-citationEffects of glucose, 2-deoxyglucose, phlorizin, and insulin on food intake of lean and fatty rats
Tsujii, S., & Bray, G. A. (1990) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1990.258.3.e476 · Cited by 40
Self-citationEffect of cimetidine suspension on appetite and weight in overweight subjects.
Birketvedt, G. S. (1993) · BMJ · doi:10.1136/bmj.306.6885.1091 · Cited by 39
Melia, A. T., Zhi, J., Koss‐Twardy, S. G., Min, B. H., Smith, B. L., Freundlich, N. L., Arora, S., & Passe, S. M. (1995) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1995.tb04128.x · Cited by 39
Marks, S. J., Moore, N., Clark, M. L., Strauss, B. J., & Hockaday, T. D. R. (1996) · Obesity Research · doi:10.1002/j.1550-8528.1996.tb00506.x · Cited by 39
Androstane-3α,17β-Diol Glucuronide as a Steroid Correlate of Visceral Obesity in Men*
Tchernof, A., Labrie, F., Bélanger, A., Prud’homme, D., Bouchard, C., Tremblay, A., Nadeau, A., & Després, J. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.5.3924 · Cited by 39
Karlsson, C., Stenlöf, K., Johannsson, G., Mårin, P., Björntorp, P. A., Bengtsson, B.-Å., Carlsson, B., Carlsson, L. M. S., & Sjöström, L. (1998) · European Journal of Endocrinology · doi:10.1530/eje.0.1380408 · Cited by 39
Obesity in childhood. A controlled trial of anorectic drugs.
Lorber, J. (1966) · Archives of Disease in Childhood · doi:10.1136/adc.41.217.309 · Cited by 38
Fluoxetine: A Randomized Clinical Trial in the Maintenance of Weight Loss
GOLDSTEIN, D. J., Rampey, A. H., Dornseif, B. E., Levine, L. R., Potvin, J. H., & Fludzinski, L. A. (1993) · Obesity Research · doi:10.1002/j.1550-8528.1993.tb00597.x · Cited by 38
Hyperphagia caused by Cerebral Ventricular Infusion of Phloridzin
Glick, Z., & Mayer, J. (1968) · Nature · doi:10.1038/2191374a0 · Cited by 38
A randomized double-blind clinical trial of fluoxetine in obese diabetics.
Gray, D. S., Fujioka, K., Devine, W., & Bray, G. A. (1992) · PubMed · Cited by 38
Self-citationFluoxetine increases resting energy expenditure and basal body temperature in humans
Bross, R., & Hoffer, L. J. (1995) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/61.5.1020 · Cited by 38
A controlled trial of phentermine in obese diabetic patients.
Campbell, C. J., Bhalla, I. P., Jm, S., & Duncan, L. J. P. (1977) · PubMed · Cited by 37
Effects of Somatostatin on Human Satiety
Lieverse, R. J., Jansen, J. B. �. �., Masclee, A., & Lamers, C. B. H. W. (2008) · Neuroendocrinology · doi:10.1159/000126831 · Cited by 37
Koegler, F. H., & Ritter, S. (1996) · Obesity Research · doi:10.1002/j.1550-8528.1996.tb00240.x · Cited by 37
Does ephedrine promote weight loss in low-energy-adapted obese women?
Pasquali, R., Cesari, M. P., Melchionda, N., Stefanini, C., Raitano, A., & Labo, G. (1987) · PubMed · Cited by 37
A review of the physiological bases of the anorexic action of phenylpropanolamine (d,l-norephedrine)
Wellman, P. J. (1990) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80043-0 · Cited by 36
Effect of intrahypothalamic hydroxybutyrate on sympathetic firing rate
Sakaguchi, T., Arase, K., & Bray, G. A. (1988) · Metabolism · doi:10.1016/0026-0495(88)90006-6 · Cited by 36
Self-citationBiological Actions of Drugs Affecting Serotonin and Eating
Garattini, S. K. (1995) · Obesity Research · doi:10.1002/j.1550-8528.1995.tb00213.x · Cited by 36
Quantitative and qualitative effects of l-triiodothyronine in massive obesity
Hollingsworth, D. R., AMATRUDA, T. T., & Scheig, R. (1970) · Metabolism · doi:10.1016/0026-0495(70)90040-5 · Cited by 36
Masserman, J. H., & GOLDSMITH, H. (1934) · JAMA · doi:10.1001/jama.1934.02750070021006 · Cited by 36
Hypophagic, endocrine and subjective responses to m‐chlorophenylpiperazine in healthy men and women
Cowen, P. J., Sargent, P. A., Williams, C., Goodall, E. M., & Orlikov, A. B. (1995) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470100504 · Cited by 36
Kolanowski, J., Younis, L. T., Vanbutsele, R., & Detry, J. M. (1992) · European Journal of Clinical Pharmacology · doi:10.1007/bf00265922 · Cited by 36
Potent and sustained satiety actions of a cholecystokinin octapeptide analogue
Moran, T. H., Sawyer, T. K., Seeb, D., Ameglio, P. J., Lombard, M., & McHugh, P. (1992) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/55.1.286s · Cited by 36
Klesges, R. C., Klesges, L. M., Meyers, A. W., Klem, M. L., & Isbell, T. R. (1990) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1990.103 · Cited by 35
Brain 3-hydroxybutyrate, glutamate, and GABA in a rat model of dietary obesity
Fisler, J. S., Shimizu, H., & Bray, G. A. (1989) · Physiology & Behavior · doi:10.1016/0031-9384(89)90075-9 · Cited by 35
Self-citationCotton, J. R., Burley, V. J., Weststrate, J. A., & Blundell, J. E. (1996) · British Journal Of Nutrition · doi:10.1079/bjn19960158 · Cited by 35
Fulghesu, A. M., Lanzone, A., Cucinelli, F., Caruso, A., & Mancuso, S. (1993) · PubMed · Cited by 35
Andersen, T., Astrup, A. V., & QUAADE, F. (1992) · PubMed · Cited by 35
Satiety effects of the type A CCK receptor antagonist loxiglumide in lean and obese women
Lieverse, R. J., Masclee, A., Jansen, J. B. �. �., Rovati, L. C., & Lamers, C. B. H. W. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(94)00136-q · Cited by 34
Methyl palmoxirate increases eating behavior and brain Fos-like immunoreactivity in rats
Horn, C. C., & Friedman, M. I. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01143-8 · Cited by 34
Angel, I., Hauger, R. L., Luu, M., Giblin, B. A., Skolnick, P., & Paul, S. M. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.18.6320 · Cited by 34
Bombesin reduces food intake in lean man by a cholecystokinin- independent mechanism
Lieverse, R. J., Jansen, J. B. �. �., van de Zwan, A., Samson, L., Masclee, A., Rovati, L. C., & Lamers, C. B. H. W. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.6.8501156 · Cited by 34
Pharmacological Treatment of Obesity
Kabra, D. G., Kabra, U. D., Tschöp, M. H., & Hofmann, S. M. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3492-4_14 · Cited by 33
Three controlled trials of weight loss with phenylpropanolamine.
Altschuler, S. M., Conte, A., Sebok, M., et al. (1982) · PubMed · Cited by 33
Dehydroepiandrosterone and Body Fat
Clore, J. N. (1995) · Obesity Research · doi:10.1002/j.1550-8528.1995.tb00234.x · Cited by 33
Intravenous enterostatin does not affect single meal food intake in man
Rössner, S., Barkeling, B., Erlanson‐Albertsson, C., Larsson, P., & W�hlin-Boll, E. (1995) · Appetite · doi:10.1016/s0195-6663(95)80004-2 · Cited by 33
Pedrinola, F., Sztejnsznajd, C., Lima, N., Halpern, A., & Medeiros-Neto, G. A. (1996) · Obesity Research · doi:10.1002/j.1550-8528.1996.tb00268.x · Cited by 33
Anorectic drugs which stimulate thermogenesis
Lang, S. S., Danforth, E., & Lien, E. L. (1983) · Life Sciences · doi:10.1016/0024-3205(83)90008-5 · Cited by 33
Effect of glucagon in macronutrient self-selection: Glucagon-enhanced protein intake
Nagai, K., Thibault, L., Nishikawa, K., Hashida, A., Ootani, K., & Nakagawa, H. (1991) · Brain Research Bulletin · doi:10.1016/0361-9230(91)90134-6 · Cited by 33
Nutrient Intake is Modulated By Peripheral Peptide Administration
Bray, G. A. (1995) · Obesity Research · doi:10.1002/j.1550-8528.1995.tb00229.x · Cited by 33
Self-citationA Comparison of Sibutramine and Dexfenfluramine in the Treatment of Obesity
Hanotin, C., Thomas, F., Jones, S. P., Leutenegger, É., & Drouin, P. (1998) · Obesity Research · doi:10.1002/j.1550-8528.1998.tb00351.x · Cited by 33
COMPARISON OF FENFLURAMINE AND METFORMIN IN TREATMENT OF OBESITY
Lawson, A. A. H., Strong, J. A., Roscoe, P., Gibson, A., & Peattie, P. (1970) · The Lancet · doi:10.1016/s0140-6736(70)90056-5 · Cited by 33
Anorexia induced in rat by D-glucosamine deoxidized at C-1
Fujimoto, K., Sakata, T., SHIRAISHI, T., Kurata, K., Terada, K., & Etou, H. (1986) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1986.251.3.r481 · Cited by 33
The effect of fluoxetine on body weight, body composition and visceral fat accumulation.
Visser, M., Seidell, J. C., Koppeschaar, H. P. F., & Smits, P. (1993) · PubMed · Cited by 32
Levin, B. E., Brown, K. L., & Dunn-Meynell, A. A. (1996) · Brain Research · doi:10.1016/s0006-8993(96)00835-9 · Cited by 32
α‐GLUCOSIDASE INHIBITION IN OBESITY
William-Olsson, T. (1986) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1986.tb19118.x · Cited by 32
Iwasaki, N., Kawamura, M., Yamagata, K., Cox, N. J., Karibe, S., Ohgawara, H., Inagaki, N., Seino, S., Bell, G. I., & Omori, Y. (1996) · Diabetes · doi:10.2337/diab.45.2.267 · Cited by 32
Dexfenfluramine in Type II diabetes: effect on weight and diabetes control
Stewart, G. O., Stein, G. R., Davis, T. M. E., & Findlater, P. (1993) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1993.tb121695.x · Cited by 32
Pasquali, R., Casimirri, F., Melchionda, N., Grossi, G., Bortoluzzi, L., Labate, A. M. M., Stefanini, C., & Raitano, A. (1992) · Clinical Science · doi:10.1042/cs0820085 · Cited by 32
Guidance for the Clinical Evaluation of Weight-Control Drugs
(2001) · Critical Reviews in Food Science and Nutrition · doi:10.1080/20014091091760 · Cited by 32
Pfohl, M., Luft, D., Blomberg, I., & Schmülling, R. M. (1994) · PubMed · Cited by 32
Chorionic Gonadotropin in Weight Control: A Double-Blind Crossover Study
Young, R. L. (1976) · JAMA · doi:10.1001/jama.236.22.2495 · Cited by 32
1-Deoxy-glucosamine initiates, then effectively suppresses feeding in the rat
Sakata, T., Fujimoto, K., Fukushima, M., Terada, K., & Arase, K. (1985) · Physiology & Behavior · doi:10.1016/0031-9384(85)90021-6 · Cited by 31
Andersson, B., Zimmermann, M. E., Hedner, T., et al. (1991) · European Journal of Clinical Pharmacology · doi:10.1007/bf00315204 · Cited by 31
Chronic ingestion of dietary fat is a prerequisite for inhibition of feeding by enterostatin
Lin, L., & York, D. A. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.275.2.r619 · Cited by 31
Goodall, E., Feeney, S. T., McGuirk, J., et al. (1992) · Psychopharmacology · doi:10.1007/bf02801976 · Cited by 30
The NAASO Position Paper on Approval and Use of Drugs to Treat Obesity
Pi‐Sunyer, X. (1995) · Obesity Research · doi:10.1002/j.1550-8528.1995.tb00177.x · Cited by 30
Cotton, J., Weststrate, J., & Blundell, J. E. (1996) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/63.6.891 · Cited by 30
Drug treatment of obesity: don’t throw the baby out with the bath water
Bray, G. A. (1998) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/67.1.1 · Cited by 30
Self-citationAtkinson, R. L., Greenway, F. L., Bray, G. A., Dahms, W. T., Molitch, M. E., Hamilton, K., & Rodin, J. (1977) · PubMed · Cited by 30
Self-citationDrent, M. L., Wever, L. D. V., Adèr, H. J., & van der Veen, E. A. (1995) · European Journal of Endocrinology · doi:10.1530/eje.0.1320565 · Cited by 29
Hauger, R. L., Hulihan-Giblin, B. A., Angel, I., Luu, M., Janowsky, A. J., Skolnick, P., & Paul, S. M. (1986) · Brain Research Bulletin · doi:10.1016/0361-9230(86)90043-2 · Cited by 29
Tremor and the anti‐obesity drug BRL 26830A.
Connacher, A. A., Lakie, M., Powers, N., Elton, R., Walsh, E. G., & Jung, R. T. (1990) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1990.tb03821.x · Cited by 29
A Study of Obese Patients in a Nutrition Clinic1
Trulson, M. F., Walsh, E., & Caso, E. K. (1947) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(21)43919-2 · Cited by 29
Scalfi, L., D'Arrigo, E., Carandente, V., Coltorti, A., & Contaldo, F. (1993) · PubMed · Cited by 29
Jéquier, E., Munger, R., & Jp, F. (1992) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/55.1.249s · Cited by 28
Fenfluramine stimulation of prolactin in obsessive-compulsive disorder
Hewlett, W. A., Vinogradov, S., Martin, K. M., Berman, S., & Csernansky, J. G. (1992) · Psychiatry Research · doi:10.1016/0165-1781(92)90041-z · Cited by 28
Willey, K. A., Molyneaux, L. M., & Yue, D. K. (1994) · Diabetic Medicine · doi:10.1111/j.1464-5491.1994.tb00336.x · Cited by 28
Influence of Dietary Composition on the Inhibition of Fat Absorption by Orlistat
Güzelhan, C., Odink, J., Jansen-Zuidema, J. J. N., & Hartmann, D. (1994) · Journal of International Medical Research · doi:10.1177/030006059402200502 · Cited by 28
The effects of a new beta-adrenoceptor agonist BRL 26830A in refractory obesity.
Bj, C., Dl, F., Sm, G., Gk, S., & Jf, M. (1988) · PubMed · Cited by 28
Clinical and basic aspects of an anorexlant, mazindol, as an antlobeslty agent in Japan
Inoue, S., Egawa, M., Satoh, S., Saito, M., Suzuki, H., Kumahara, Y., Abe, M., Kumagai, A., Gotō, Y., & Shizume, K. (1992) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/55.1.199s · Cited by 27
Phenylpropanolamine and blood pressure: a review of prospective studies
Morgan, J., & Funderburk, F. R. (1992) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/55.1.206s · Cited by 27
Jenner, P. G. (1986) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.49.10.1211 · Cited by 27
Scheen, A. J., Letiexhe, M. R., & Lefèbvre, P. J. (1995) · Diabetic Medicine · doi:10.1111/j.1464-5491.1995.tb00410.x · Cited by 27
Truant, A. P., Olon, L. P., & Cobb, S. (1972) · PubMed · Cited by 27
Valle‐Jones, J. C., Brodie, N., O'Hara, H., O'Hara, J., & McGhie, R. L. (1983) · PubMed · Cited by 26
Clinical studies with d-fenfluramine
Guy-grand, B. (1992) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/55.1.173s · Cited by 26
Sequencing of behavior therapy and pharmacotherapy for obesity.
Craighead, L. W. (1984) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.52.2.190 · Cited by 26
A CONTROLLED INVESTIGATION OF THE " GLYCOLYPTIC " ACTION OF FENFLURAMINE
Garrow, J. S. (1972) · The Lancet · doi:10.1016/s0140-6736(72)91957-5 · Cited by 26
Hormonal Responses to Fenfluramine in Depressive Subtypes
Mitchell, P. B., Smythe, G. A., Parker, G. B., Wilhelm, K. A., Hickie, I. B., Brodaty, H., & Boyce, P. M. (1990) · The British Journal of Psychiatry · doi:10.1192/bjp.157.4.551 · Cited by 26
β-Adrenoceptor Subtypes Mediating the Metabolic Effects of BRL 35135 in Man
Wheeldon, N., McDevitt, D. G., McFarlane, L. C., & Lipworth, B. J. (1994) · Clinical Science · doi:10.1042/cs0860331 · Cited by 26
Yohimbine does not affect fat distribution in men.
Sax, L. (1991) · PubMed · Cited by 25
Insulin Normalization as an Approach to the Pharmacological Treatment of Obesity
Campfield, L. A., Smith, F. J., Mackie, G., Tenenbaum, R., Sassano, M. L., Mullin, J., Kaiser, K., & Kierstead, R. W. (1995) · Obesity Research · doi:10.1002/j.1550-8528.1995.tb00231.x · Cited by 25
Inoue, S., Nagase, H., Satom, S., Saito, M., Egawa, M., Tanaka, K., & Takamura, Y. (1991) · Brain Research Bulletin · doi:10.1016/0361-9230(91)90151-9 · Cited by 24
Obesity and Weight Control: The Health Professional's Guide to Understanding and Treatment
(1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-110-9-754_3 · Cited by 24
A Multicentre Study Comparing Mazindol and Placebo in Obese Patients
Walker, B. R., Ballard, I. M., & Gold, J. A. (1977) · Journal of International Medical Research · doi:10.1177/030006057700500202 · Cited by 24
Shapira, B., Cohen, J., Newman, M. E., & Lerer, B. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90008-2 · Cited by 24
Cimetidine suspension as adjuvant to energy restricted diet in treating obesity.
Rasmussen, M. H., Andersen, T., Breum, L., Gøtzsche, P. C., & Hilsted, J. (1993) · BMJ · doi:10.1136/bmj.306.6885.1093 · Cited by 24
Andersen, P. H., Richelsen, B., Bak, J. F., Schmitz, O., Sørensen, N. S., Lavielle, R., & Pedersen, O. (1993) · European Journal of Endocrinology · doi:10.1530/acta.0.1280251 · Cited by 24
Cited by
Barlow, S. E., & and the Expert Committee (2007) · Pediatrics · doi:10.1542/peds.2007-2329c · Cited by 4,497
Lau, D. C. W., Douketis, J. D., Morrison, K. M., Hramiak, I. M., Sharma, A. M., Ur, E., & Panel, F. M. O. T. O. C. C. P. G. E. (2007) · Canadian Medical Association Journal · doi:10.1503/cmaj.061409 · Cited by 1,154
Recommendations for Treatment of Child and Adolescent Overweight and Obesity
Spear, B. A., Barlow, S. E., Ervin, C., Ludwig, D. S., Saelens, B. E., Schetzina, K. E., & Taveras, E. M. (2007) · Pediatrics · doi:10.1542/peds.2007-2329f · Cited by 856
Meta-Analysis: Pharmacologic Treatment of Obesity
Li, Z., Maglione, M., Tu, W., Mojica, W., Arterburn, D., Shugarman, L. R., Hilton, L., Suttorp, M., Solomon, V., Shekelle, P. G., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-7-200504050-00012 · Cited by 774
Appropriate Intervention Strategies for Weight Loss and Prevention of Weight Regain for Adults
JAKICIC (CHAIR), J. M., CLARK, K., COLEMAN, E., DONNELLY, J. E., FOREYT, J., MELANSON, E., VOLEK, J., & VOLPE, S. L. (2001) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-200112000-00026 · Cited by 752
Metadata
- Authors
- Bray, G. A., & Greenway, F. L.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 1999-12-01
- Volume
- 20
- Issue
- 6
- Pages
- 805-875
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2007700773
- Cited by
- 331
- References
- 722
- FWCI
- 10.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.